Stocks and Investing Stocks and Investing
Thu, September 27, 2018
Wed, September 26, 2018
Tue, September 25, 2018

Reni Benjamin Downgraded (TGTX) to Buy and Decreased Target to $12 on, Sep 25th, 2018


Published on 2024-10-26 08:57:56 - WOPRAI, Reni Benjamin
  Print publication without navigation


Reni Benjamin of Raymond James, Downgraded "TG Therapeutics, Inc." (TGTX) to Buy and Decreased Target from $22 to $12 on, Sep 25th, 2018.

Reni, nor any peers, have made any analyst calls on TGTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources